SARS-CoV-2 and Coronavirus Disease Mitigation: Treatment Options, Vaccinations and Variants

Almu’atasim Khamees; Jamal Bani-issa; Mazhar Salim Al Zoubi; Taqwa Qasem; Manal Issam Abualarjah; Sura Ahmad Alawadin; Khayry Al-shami; Farah E. Hussein; Emad Hussein; Ibrahim H. Bashayreh; Murtaza M. Tambuwala; Mohannad Al-saghir; Christopher T. Cornelison

doi:10.3390/pathogens11020275

SARS-CoV-2 and Coronavirus Disease Mitigation: Treatment Options, Vaccinations and Variants

Almu’atasim Khamees, Jamal Bani-issa, Mazhar Salim Al Zoubi, Taqwa Qasem, Manal Issam Abualarjah, Sura Ahmad Alawadin, Khayry Al-shami, Farah E. Hussein, Emad Hussein, Ibrahim H. Bashayreh, Murtaza M. Tambuwala, Mohannad Al-saghir, Christopher T. Cornelison

Research output: Contribution to journal › Review article › peer-review

12 Citations (Scopus)

190 Downloads (Pure)

Abstract

COVID-19 is caused by a novel coronavirus (2019-nCoV), which was declared as a pandemic after it emerged in China 2019. A vast international effort has been conducted to prevent and treat COVID-19 due to its high transmissibility and severe morbidity and mortality rates, particularly in individuals with chronic co-morbidities. In addition, polymorphic variants increased the need for proper vaccination to overcome the infectivity of new variants that are emerging across the globe. Many treatment options have been proposed and more than 25 vaccines are in various stages of development; however, the infection peaks are oscillating periodically, which raises a significant question about the effectiveness of the prevention measures and the persistence of this pandemic disease. In this review, we are exploring the most recent knowledge and advances in the treatment and vaccination options as well as the new emerging variants of 2019-nCoV and the possible mitigation of one of the most aggressive pandemics in the last centuries.

Original language	English
Article number	275
Pages (from-to)	1-38
Number of pages	38
Journal	Pathogens
Volume	11
Issue number	2
DOIs	https://doi.org/10.3390/pathogens11020275
Publication status	Published (in print/issue) - 20 Feb 2022

Bibliographical note

Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.

Keywords

vaccines
pandemic
COVID-19
variants
Pandemic
2019-nCoV

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3390/pathogens11020275Licence: CC BY

pathogens-11-00275-v2Final published version, 2.36 MBLicence: CC BY

Cite this

Khamees, A., Bani-issa, J., Zoubi, M. S. A., Qasem, T., Abualarjah, M. I., Alawadin, S. A., Al-shami, K., Hussein, F. E., Hussein, E., Bashayreh, I. H., Tambuwala, M. M., Al-saghir, M., & Cornelison, C. T. (2022). SARS-CoV-2 and Coronavirus Disease Mitigation: Treatment Options, Vaccinations and Variants. Pathogens, 11(2), 1-38. Article 275. https://doi.org/10.3390/pathogens11020275

@article{431f2da7191e416fa6ad23fb9c9bf39f,

title = "SARS-CoV-2 and Coronavirus Disease Mitigation: Treatment Options, Vaccinations and Variants",

abstract = "COVID-19 is caused by a novel coronavirus (2019-nCoV), which was declared as a pandemic after it emerged in China 2019. A vast international effort has been conducted to prevent and treat COVID-19 due to its high transmissibility and severe morbidity and mortality rates, particularly in individuals with chronic co-morbidities. In addition, polymorphic variants increased the need for proper vaccination to overcome the infectivity of new variants that are emerging across the globe. Many treatment options have been proposed and more than 25 vaccines are in various stages of development; however, the infection peaks are oscillating periodically, which raises a significant question about the effectiveness of the prevention measures and the persistence of this pandemic disease. In this review, we are exploring the most recent knowledge and advances in the treatment and vaccination options as well as the new emerging variants of 2019-nCoV and the possible mitigation of one of the most aggressive pandemics in the last centuries.",

keywords = "vaccines, pandemic, COVID-19, variants, Pandemic, 2019-nCoV",

author = "Almu{\textquoteright}atasim Khamees and Jamal Bani-issa and Zoubi, {Mazhar Salim Al} and Taqwa Qasem and Abualarjah, {Manal Issam} and Alawadin, {Sura Ahmad} and Khayry Al-shami and Hussein, {Farah E.} and Emad Hussein and Bashayreh, {Ibrahim H.} and Tambuwala, {Murtaza M.} and Mohannad Al-saghir and Cornelison, {Christopher T.}",

note = "Publisher Copyright: {\textcopyright} 2022 by the authors. Licensee MDPI, Basel, Switzerland.",

year = "2022",

month = feb,

day = "20",

doi = "10.3390/pathogens11020275",

language = "English",

volume = "11",

pages = "1--38",

journal = "Pathogens",

issn = "2076-0817",

publisher = "MDPI AG",

number = "2",

}

TY - JOUR

T1 - SARS-CoV-2 and Coronavirus Disease Mitigation: Treatment Options, Vaccinations and Variants

AU - Khamees, Almu’atasim

AU - Bani-issa, Jamal

AU - Zoubi, Mazhar Salim Al

AU - Qasem, Taqwa

AU - Abualarjah, Manal Issam

AU - Alawadin, Sura Ahmad

AU - Al-shami, Khayry

AU - Hussein, Farah E.

AU - Hussein, Emad

AU - Bashayreh, Ibrahim H.

AU - Tambuwala, Murtaza M.

AU - Al-saghir, Mohannad

AU - Cornelison, Christopher T.

PY - 2022/2/20

Y1 - 2022/2/20

N2 - COVID-19 is caused by a novel coronavirus (2019-nCoV), which was declared as a pandemic after it emerged in China 2019. A vast international effort has been conducted to prevent and treat COVID-19 due to its high transmissibility and severe morbidity and mortality rates, particularly in individuals with chronic co-morbidities. In addition, polymorphic variants increased the need for proper vaccination to overcome the infectivity of new variants that are emerging across the globe. Many treatment options have been proposed and more than 25 vaccines are in various stages of development; however, the infection peaks are oscillating periodically, which raises a significant question about the effectiveness of the prevention measures and the persistence of this pandemic disease. In this review, we are exploring the most recent knowledge and advances in the treatment and vaccination options as well as the new emerging variants of 2019-nCoV and the possible mitigation of one of the most aggressive pandemics in the last centuries.

AB - COVID-19 is caused by a novel coronavirus (2019-nCoV), which was declared as a pandemic after it emerged in China 2019. A vast international effort has been conducted to prevent and treat COVID-19 due to its high transmissibility and severe morbidity and mortality rates, particularly in individuals with chronic co-morbidities. In addition, polymorphic variants increased the need for proper vaccination to overcome the infectivity of new variants that are emerging across the globe. Many treatment options have been proposed and more than 25 vaccines are in various stages of development; however, the infection peaks are oscillating periodically, which raises a significant question about the effectiveness of the prevention measures and the persistence of this pandemic disease. In this review, we are exploring the most recent knowledge and advances in the treatment and vaccination options as well as the new emerging variants of 2019-nCoV and the possible mitigation of one of the most aggressive pandemics in the last centuries.

KW - vaccines

KW - pandemic

KW - COVID-19

KW - variants

KW - Pandemic

KW - 2019-nCoV

UR - https://www.mdpi.com/2076-0817/11/2/275

UR - http://www.scopus.com/inward/record.url?scp=85125086813&partnerID=8YFLogxK

U2 - 10.3390/pathogens11020275

DO - 10.3390/pathogens11020275

M3 - Review article

C2 - 35215217

SN - 2076-0817

VL - 11

SP - 1

EP - 38

JO - Pathogens

JF - Pathogens

IS - 2

M1 - 275

ER -

SARS-CoV-2 and Coronavirus Disease Mitigation: Treatment Options, Vaccinations and Variants

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this